Cook Unveils Advance Drug-Eluting Balloon at ISET 2009
February 2, 2009 - Cook Medical’s new Advance PTX drug-eluting balloon was used in a live case transmitted from The Heart Center Leipzig/Park Hospital in Leipzig, Germany, at last week’s ISET 2009 International Symposium on Endovascular Therapy.
The Advance PTX is designed to increase long-term patency in patients with peripheral arterial disease (PAD) and is one of the first PTA balloon catheters to be coated with paclitaxel, an antiproliferative drug that has been used successfully to reduce the risk of arterial restenosis following angioplasty in coronary disease patients.
Cook also introduced several products from its premier line of diagnostic and peripheral interventional devices at ISET 2009, including its Approach CTO microwires. The Approach CTO microwires are the first .014-inch wires designed specifically for crossing chronic total occlusions and extremely tight lesions in the peripheral arteries, including the SFA, popliteal and tibial arteries.
For more information: www.iset.org, www.cookmedical.com
More like this
- Drug-Eluting Balloons May Breath New Life into Nonstent Angioplasty
- European Trial Explores Potential of Renal Stent
- Bard Completes Enrollment in IDE Drug-Coated Balloon Trial
- Study Reveals 86.2 Percent SFA Patency With Self-Expanding DES
- First Patient Enrolled in Lutonix U.S. Drug-Coated Balloon Pivotal Trial